Skip Ribbon Commands
Skip to main content
Translate
Translate
menu iconMenu
search iconSearch

Urologic Oncologist Kellogg Parsons, MD, Recognized as Health Leader

 

August 13, 2009  |   

Kellogg Parsons, MD, urologic oncologist at UC San Diego Medical Center and Moores UCSD Cancer Center, has recently received multiple recognitions for his leadership in the field of urology and cancer care. He has been appointed to the prestigious American Urological Association (AUA) Practice Guidelines Committee. Reaching a global community of physicians, the committee recommends specific indications, guidelines and practice parameters for diagnosis and treatment of urological diseases, outlining appropriate procedures for care. Parsons is currently their youngest member.

Kellog Parsons, MD

Parsons is a national expert in prostate cancer prevention

As a graduate of the 2009 AUA Leadership Program, Parsons was one of only two urologists the Western United States selected for this national training program. His paper, “Alcohol Consumption is Associated with Decreased Risk of Benign Prostatic Hyperplasia” received second place in the American Urological Association National Clinical Research Contest and will be published later this year in The Journal of Urology.

“Dr. Parsons is a superb surgeon-scientist whose research into the causes, prevention and treatment of prostate cancer will have a profound impact on patient care in the coming years,” said Christopher Kane, MD, FACS, chief of urology at UC San Diego Medical Center. “He is one of the reasons that the urology program at UC San Diego Medical Center is top ranked by US News & World Report.”

Parsons’ clinical practice focuses on the minimally-invasive treatment of urological malignancies, including prostate, kidney, and bladder cancer. He has specialized training in minimally-invasive laparoscopic and robotic surgical techniques designed to reduce pain and speed recovery time. He is currently lead investigator of an NIH-funded pilot study called, “The Dietary Intervention for Bladder Cancer Study.”

Patients interested in meeting Parsons and a multidisciplinary team of cancer specialists may attend a free community seminar on advances in treating prostate cancer on Thursday, September 17, 2009 from 6:30—8:00 pm at Moores UCSD Cancer Center. The seminar is being offered in recognition of Prostate Cancer Awareness Month. More information about the seminar may be obtained by calling 800-926-UCSD.

# # #

Media Contact: Jackie Carr, 619-543-6163, jcarr@ucsd.edu



Media Contact

Related News

4/22/2015
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year ...
4/20/2015
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and p ...
4/20/2015
A decrease in the amount of time spent eating and an increase in overnight fasting reduces glucose levels and may reduce the risk of breast cancer among women, report University of California, San Die ...
4/20/2015
The threat of falsified medications, also referred to as counterfeit, fraudulent, and substandard, can be quite real, yet the full scope and prevalence of the problem is poorly understood, say researc ...
4/17/2015
Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices us ...
4/16/2015
The increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation t ...
4/16/2015
An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardi ...
4/13/2015
About one quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to a new study by researchers at Universit ...